Henry Han
@hancardiomd.bsky.social
650 followers 120 following 120 posts
Cardiologist MBBS, MD, FACC, FESC | Physician-Sci & Researcher MPH | #HeartFailure 🧑‍⚕️| #HFA & #EACVI Committee @escardio | Content Catalyst in @TCTMD
Posts Media Videos Starter Packs
Pinned
hancardiomd.bsky.social
Applying the ‘touch-and-go’ concept to #MRAs : A paradigm shift in routine heart failure management

Addressing the barriers: rethinking WRF and #hyperkalaemia

onlinelibrary.wiley.com/doi/abs/10.1... @escardio.bsky.social @anastasiasmihaili.bsky.social @shelleyzieroth.bsky.social
Reposted by Henry Han
tctmd.bsky.social
Adding digitoxin to contemporary GDMT improves clinical outcomes in patients who have HFrEF, according to results from the DIGIT-HF trial. Read more here:
#ESCCongress2025 www.tctmd.com/news/digitox...
Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF
(UPDATED) The effect size was modest, but the glycoside improved clinical outcomes when added to GDMT.
www.tctmd.com
Reposted by Henry Han
novitham.bsky.social
#ESCGuidelines on #Myocarditis & #Pericarditis🫀

📍umbrella term: Inflammatory Myopericardial Syndrome used until diagnosis is clarified
📍Emphasizes use of #whyCMR
📍Clear recommendation for #EMB
📍Genetic & inherited CMPs highlighted🧬

🔗: doi.org/10.1093/eurhea…#ESCCongressss @escardio.bsky.social
hancardiomd.bsky.social
The Continuum of Prevention and Heart Failure in Cardiovascular Medicine: A Joint Scientific Statement from the Heart Failure Society of America and The American Society for Preventive Cardiology

onlinejcf.com/article/S107...
@drmarthagulati.bsky.social @dranulala.bsky.social @jcardfail.bsky.social
Reposted by Henry Han
hancardiomd.bsky.social
Conduction system pacing: promoting the physiology to prevent HF

Background and Clinical perspectives of HBP and LBBP area in HF
link.springer.com/article/10.1...

#HF #CardioSky #CardioEd @cardioobdoc.bsky.social @drrajivsankar.bsky.social @annakatebarton.bsky.social @vietheartpa.bsky.social
Reposted by Henry Han
pabloplopez.bsky.social
🚀 Want to stay updated with the latest from #EHJCVI and #EHJIMP? 📷 Follow our amazing Social Media Editors! 📷
@EHJCVIEiC & @EHJIMPEiC, our Editors-in-Chief bringing the latest to your feed! @escardio.bsky.social @jgrapsa.bsky.social @hancardiomd.bsky.social
hancardiomd.bsky.social
Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis

#Colchicine significantly reduced #MACE in patients with vascular disease: pooled HR 0.75 (95% CI 0.56–0.93) across 6 RCTs (n=21,800).

#CardioSky @escardio.bsky.social
hancardiomd.bsky.social
Evolution of Critical Care Cardiology: An Update on Structure, Care Delivery, Training, and Research Paradigms: A Scientific Statement From the American Heart Association

#CCU #CICU #JACC #CardioSky @jaccjournals.bsky.social @americanheart.bsky.social @accintouch.bsky.social
hancardiomd.bsky.social
Phase 3 trial of PO #Orforglipron ; lowering A1C by an average of 1.3% to 1.6% across doses

Once-daily oral pill reduced weight by an average 16.0 lbs (7.9%) at the highest dose in a key S’ endpoint

@tctmd.bsky.social @mmamas1973.bsky.social @shelleyzieroth.bsky.social @drmarthagulati.bsky.social
hancardiomd.bsky.social
Gaps and Knowledge in the Contemporary Management of Acute Right Ventricular Failure

www.ahajournals.org/doi/10.1161/...

@ahascience.bsky.social #RVFailure #HeartFailure #CardioEd @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @mmamas1973.bsky.social @mirvz.bsky.social
hancardiomd.bsky.social
#Cancer and #CVD are intertwined, with inflammation and a dysregulated immune system being common contributors

Shared Mechanisms in Cancer and #CVD : #S100A8/9 and the #NLRP3 #Inflammasome

#CardioSky #OncoSky @cardioobdoc.bsky.social @novitham.bsky.social @pnatarajanmd.bsky.social
hancardiomd.bsky.social
This study aimed to characterize HF with supranormal EF (HFsnEF) using different LVEF cutoffs (35%, 55%, and 70% for men, and 40%, 60%, and 75% for women).
onlinelibrary.wiley.com/doi/full/10....
@escardio.bsky.social @hvanspall.bsky.social @erinmichos.bsky.social @docbhardwaj.bsky.social
hancardiomd.bsky.social
Clinical and plasma proteomic characterization of heart failure with supranormal left ventricular ejection fraction: An emerging entity of heart failure

#EJHF @escardio.bsky.social
#CardioSky @shelleyzieroth.bsky.social @jimjanuzzi.bsky.social @drmarthagulati.bsky.social @cardioobdoc.bsky.social
Reposted by Henry Han
hancardiomd.bsky.social
#Aldosterone-targeted therapies: early implementation in resistant #HTN and #CKD

Reflecting on the fundamentals and exploring future directions

academic.oup.com/eurheartj/ad...
#CardioSky @escardio.bsky.social #EHJ @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social